Byotrol breakthrough ensures healthcare hygiene regimes maintained

For anyone involved in the maintenance of hygiene standards in the healthcare sector, one of the greatest challenges they are likely to face is getting staff to follow procedures correctly, every time they wash their hands.

Hygiene advisers recommend that healthcare professionals should clean their hands for at least 30 seconds using an approved disinfectant but in the majority of cases this never happens and results in potentially high levels of residual bacteria on the hands.

Now anti-bacterial technology company Byotrol plc has developed a solution to this problem which makes it extremely easy for people cleaning their hands to do so for the prescribed 30 seconds. And equally importantly because the product is alcohol free, it is kind to skin and thus minimises the risk of users acquiring dermatitis through regular exposure to harsh cleaners.

Available for care homes as a pump action hand held mousse under the assure brand name, the product remains wet on the hands for 30 seconds and staff are simply instructed to place a small amount on their hands and rub it in and clean their hands until the Byotrol foam dries and disappears, thus providing a simple self timing mechanism

Importantly, as well as ensuring staff follow hygiene regimes correctly, the Byotrol technology offers healthcare professionals a number of other benefits as well as its kindness to skin.

The alcohol free formulation means it does not sting if rubbed into a small cut and this gets round the problem of people avoiding cleaning cuts which in reality are most likely to harbour bacteria. Equally crucial is the fact that Byotrol's technology offers long lasting efficacy and continues to work against a broad spectrum of bacteria including Listeria and MRSA even after it has dried. And because of how Byotrol works, bacteria are highly unlikely to be able to develop resistance to the technology.

This innovation is the latest in a series of key developments in hand hygiene by the Manchester based company which has recently received CE Mark approval for its technology to be used in the medical sector across Europe and and EPA approval in the United States which allows Byotrol to be used as a disinfectant in a wide range of sectors including healthcare and medical.

According to Byotrol's Business Development Director Stephen Falder, "We have combined a breakthrough technology with a delivery mechanism that greatly increases the chance of hygiene procedures being followed correctly and we are confident that if our products are used in the appropriate manner they can play a key role in reducing bacterial transmission in a healthcare setting."

-          ends –

Media calls to:

Jim Rothnie or Ruth Douglass

McCann Erickson PR

T: 01625 822614

E: jim.rothnie@europe.mccann.com / ruth.douglass@europe.mccann.com

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

BMA suspends GP committee election to investigate potential rule breach

BMA suspends GP committee election to investigate potential rule breach

The BMA has suspended voting in part of its GP committee election as it investigates...

Thousands of overseas GPs recognised for 'extraordinary contribution' to NHS

Thousands of overseas GPs recognised for 'extraordinary contribution' to NHS

GP leaders have recognised the extraordinary contribution of thousands of overseas-qualified...

GPs report concerns over BMA GP committee elections

GPs report concerns over BMA GP committee elections

Elections for nearly one in four regional BMA GP committee seats are underway, but...

UK hits 1m second doses of COVID-19 vaccine as campaign shifts to next phase

UK hits 1m second doses of COVID-19 vaccine as campaign shifts to next phase

More than 1m people UK-wide have now had two doses of COVID-19 vaccine, official...

What GPs need to know about the GMC's new guidance on prescribing

What GPs need to know about the GMC's new guidance on prescribing

MDU medico-legal adviser Kathryn Leask explains the key issues GPs need to be aware...